Suppr超能文献

共病:对健康心理学和行为医学的影响和方向。

Multimorbidity: Implications and directions for health psychology and behavioral medicine.

机构信息

Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute.

Basic Biobehavioral and Psychological Sciences Branch, Behavioral Research Program, National Cancer Institute.

出版信息

Health Psychol. 2019 Sep;38(9):772-782. doi: 10.1037/hea0000762.

Abstract

The increasing prevalence of multimorbidity in the United States and the rest of the world poses problems for patients and for health care providers, care systems, and policy. After clarifying the difference between comorbidity and multimorbidity, this article describes the challenges that the prevalence of multimorbidity presents for well-being, prevention, and medical treatment. We submit that health psychology and behavioral medicine have an important role to play in meeting these challenges because of the holistic vision of health afforded by the foundational biopsychosocial model. Furthermore, opportunities abound for health psychology/behavioral medicine to study how biological, social and psychological factors influence multimorbidity. This article describes three major areas in which health psychologists can contribute to understanding and treatment of multimorbidity: (a) etiology; (b) prevention and self-management; and (c) clinical care. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

摘要

在美国和世界其他地区,多种疾病的发病率不断上升,给患者和医疗服务提供者、护理系统和政策带来了问题。本文在澄清了合并症和多种疾病之间的区别后,描述了多种疾病的流行给幸福感、预防和治疗带来的挑战。我们认为,健康心理学和行为医学在应对这些挑战方面发挥着重要作用,因为基础的生物心理社会模型提供了健康的整体视野。此外,健康心理学/行为医学有很多机会研究生物、社会和心理因素如何影响多种疾病。本文描述了健康心理学家可以为理解和治疗多种疾病做出贡献的三个主要领域:(a)病因;(b)预防和自我管理;(c)临床护理。(心理学文摘数据库记录(c)2019APA,保留所有权利)。

相似文献

1
Multimorbidity: Implications and directions for health psychology and behavioral medicine.
Health Psychol. 2019 Sep;38(9):772-782. doi: 10.1037/hea0000762.
2
Multimorbidity in health psychology and behavioral medicine.
Health Psychol. 2019 Sep;38(9):769-771. doi: 10.1037/hea0000783.
3
Preventing and managing multimorbidity by integrating behavioral health and primary care.
Health Psychol. 2019 Sep;38(9):851-854. doi: 10.1037/hea0000787.
4
The Yale Roadmap for Health Psychology and Integrated Cardiovascular Care.
Health Psychol. 2022 Oct;41(10):779-791. doi: 10.1037/hea0001152. Epub 2022 Feb 24.
5
Multimorbidity in randomized controlled trials of behavioral interventions: A systematic review.
Health Psychol. 2019 Sep;38(9):831-839. doi: 10.1037/hea0000726. Epub 2019 May 2.
6
Health Psychology adopts Transparency and Openness Promotion (TOP) Guidelines.
Health Psychol. 2021 Apr;40(4):227-229. doi: 10.1037/hea0001074.
7
A Biobehavioral Framework to Address the Emerging Challenge of Multimorbidity.
Psychosom Med. 2016 Apr;78(3):281-9. doi: 10.1097/PSY.0000000000000294.
8
Inflammation in multimorbidity and disability: An integrative review.
Health Psychol. 2019 Sep;38(9):791-801. doi: 10.1037/hea0000749.
9
Exercise in people with comorbidity or multimorbidity.
Health Psychol. 2019 Sep;38(9):822-830. doi: 10.1037/hea0000750. Epub 2019 Apr 25.
10
The Behavioral Medicine Research Council: Its origins, mission, and methods.
Health Psychol. 2019 Apr;38(4):277-289. doi: 10.1037/hea0000731.

引用本文的文献

1
Multimorbidity: Addressing the Elephant in the Clinic Room.
Healthcare (Basel). 2025 May 21;13(10):1202. doi: 10.3390/healthcare13101202.
3
Analytical approaches to evaluate risk factors of multimorbidity: a systematic scoping review protocol.
BMJ Open. 2025 Jan 28;15(1):e083278. doi: 10.1136/bmjopen-2023-083278.
5
The Importance of Including Long COVID Outcomes When Developing Novel Treatments for Acute COVID-19.
J Infect Dis. 2024 Oct 16;230(4):789-796. doi: 10.1093/infdis/jiae270.
6
Reviews for multimorbidity risk in people with inflammatory conditions: a qualitative study.
BJGP Open. 2024 Oct 29;8(3). doi: 10.3399/BJGPO.2024.0011. Print 2024 Oct.
9
Personalized (N-of-1) Trials for Patient-Centered Treatments of Multimorbidity.
Harv Data Sci Rev. 2022;4(SI3). doi: 10.1162/99608f92.d99e6ff5. Epub 2022 Sep 8.

本文引用的文献

1
Extent of Exclusions for Chronic Conditions in Breast Cancer Trials.
JNCI Cancer Spectr. 2018 Dec 11;2(4):pky059. doi: 10.1093/jncics/pky059. eCollection 2018 Oct.
2
Multimorbidity in randomized controlled trials of behavioral interventions: A systematic review.
Health Psychol. 2019 Sep;38(9):831-839. doi: 10.1037/hea0000726. Epub 2019 May 2.
3
Multimorbidity and Comorbidity are now separate MESH headings.
J Clin Epidemiol. 2019 Jan;105:vi-viii. doi: 10.1016/j.jclinepi.2018.11.019.
4
Key factors to consider when measuring multimorbidity: Results from an expert panel and online survey.
J Comorb. 2018 Sep 3;8(1):2235042X18795306. doi: 10.1177/2235042X18795306. eCollection 2018 Jan-Dec.
5
Expanding the Evidence Base in Geriatric Oncology: Action Items From an FDA-ASCO Workshop.
J Natl Cancer Inst. 2018 Nov 1;110(11):1163-1170. doi: 10.1093/jnci/djy169.
6
Smoking as a risk factor for lung cancer in women and men: a systematic review and meta-analysis.
BMJ Open. 2018 Oct 3;8(10):e021611. doi: 10.1136/bmjopen-2018-021611.
7
A rehabilitation programme for people with multimorbidity versus usual care: A pilot randomized controlled trial.
J Comorb. 2018 Jul 20;8(1):2235042X18783918. doi: 10.1177/2235042X18783918. eCollection 2018.
8
Predicting Incident Multimorbidity.
Ann Fam Med. 2018 Jul;16(4):322-329. doi: 10.1370/afm.2271.
9
Multimorbidity Trends in United States Adults, 1988-2014.
J Am Board Fam Med. 2018 Jul-Aug;31(4):503-513. doi: 10.3122/jabfm.2018.04.180008.
10
Defining and measuring multimorbidity: a systematic review of systematic reviews.
Eur J Public Health. 2019 Feb 1;29(1):182-189. doi: 10.1093/eurpub/cky098.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验